Back to search

Radiance Therapeutics Ltd

12032088

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

48 ARWENACK STREET, FALMOUTH, TR11 3JH
Incorporated 04/06/2019

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Laurence John Marsteller

director · Since 04/06/2019

MEDICAL DOCTOR

AMERICAN · UNITED STATES · Age 67

CompanyRankvs 1510+ SIC 72110 peers
51

Financial strength24th percentile among SIC peers · 6/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 13.67× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength6/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 20/06/2025

Net Worth

£1

Balance sheet strength

Cash

£15k

Cash in the bank

Net Current Assets

£19k

Working capital

Current Assets

£21k

Current Liabilities

£2k

Debtors

£6k

Profit After Tax

-£10k

0avg. employees

Balance Sheet

Assets less current liabilities£19k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202513.67
202513.67
20248.26-£106k
20230.95+£113k
202211.06+£505
20211.36+£5k
20203.34+£7k
20190.35

Derived from filed accounts. Not audited figures.